| $158M | ||
| $148M | ||
| $100M | ||
| $27M | ||
| $21M | ||
| $16M |
Buys | $1,074,000 | 5 | 100 |
Sells | $0 | 0 | 0 |
| Salkind Gene | director | 2 | $673,500 | 0 | $0 | $673,500 |
| MARSHALL ALLAN | Chief Executive Officer | 3 | $400,500 | 0 | $0 | $400,500 |
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management …
Over the last 12 months, insiders at Upexi, Inc. have bought $1.07M and sold $0 worth of Upexi, Inc. stock.
On average, over the past 5 years, insiders at Upexi, Inc. have bought $1.1M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Salkind Gene (director) — $673,500. MARSHALL ALLAN (Chief Executive Officer) — $400,500.
The last purchase of 50,000 shares for transaction amount of $90,000 was made by MARSHALL ALLAN (Chief Executive Officer) on 2025‑12‑23.
| 2025-12-23 | MARSHALL ALLAN | Chief Executive Officer | 50,000 0.0748% | $1.80 | $90,000 | -42.66% | ||
| 2025-12-16 | MARSHALL ALLAN | Chief Executive Officer | 50,000 0.0835% | $2.07 | $103,500 | -48.29% | ||
| 2025-12-15 | MARSHALL ALLAN | Chief Executive Officer | 100,000 0.1674% | $2.07 | $207,000 | -48.04% | ||
| 2025-11-20 | Salkind Gene | director | 50,000 0.0861% | $2.55 | $127,500 | -56.28% | ||
| 2025-11-17 | Salkind Gene | director | 200,000 0.3512% | $2.73 | $546,000 | -58.46% | ||
| 2025-07-22 | Dugan Lawrence | director | 4,000 0.0103% | $7.50 | $30,000 | -75.71% | ||
| 2025-07-16 | Dugan Lawrence | director | 11,000 0.0227% | $5.69 | $62,600 | -73.69% | ||
| 2025-07-15 | Dugan Lawrence | director | 1,000 0.0026% | $5.17 | $5,170 | -62.31% | ||
| 2025-07-11 | MARSHALL ALLAN | Chief Executive Officer | 161,943 0.1554% | $4.94 | $799,998 | -63.17% | ||
| 2025-07-11 | Salkind Gene | 20,243 0.0194% | $4.94 | $100,000 | -63.17% | |||
| 2025-04-17 | MARSHALL ALLAN | Chief Executive Officer | 657,895 56.0777% | $2.28 | $1.5M | +83.26% | ||
| 2025-04-17 | Salkind Gene | 241,229 20.5619% | $2.28 | $550,002 | +83.26% | |||
| 2025-04-17 | Norstrud Andrew James | Chief Financial Officer | 43,860 3.7385% | $2.28 | $100,001 | +83.26% | ||
| 2024-03-12 | MARSHALL ALLAN | CHIEF EXECUTIVE OFFICER | 64,150 0.7349% | $0.57 | $36,566 | -51.35% | ||
| 2024-03-11 | MARSHALL ALLAN | CHIEF EXECUTIVE OFFICER | 13,623 0.1643% | $0.60 | $8,174 | -56.38% | ||
| 2024-03-05 | MARSHALL ALLAN | CHIEF EXECUTIVE OFFICER | 103,013 1.4493% | $0.70 | $72,109 | -53.97% | ||
| 2023-12-15 | MARSHALL ALLAN | CHIEF EXECUTIVE OFFICER | 4,535 0.0829% | $0.91 | $4,127 | -52.10% | ||
| 2023-12-14 | MARSHALL ALLAN | CHIEF EXECUTIVE OFFICER | 8,381 0.1651% | $0.98 | $8,213 | -55.16% | ||
| 2023-12-07 | MARSHALL ALLAN | CHIEF EXECUTIVE OFFICER | 90,001 1.7074% | $0.94 | $84,952 | -59.56% | ||
| 2023-12-05 | MARSHALL ALLAN | CHIEF EXECUTIVE OFFICER | 19,296 0.3275% | $0.84 | $16,294 | -53.00% |
| MARSHALL ALLAN | Chief Executive Officer | 4046261 4.5887% | $3.01M | 27 | 0 | <0.0001% |
| Salkind Gene | director | 218750 0.2481% | $162,925.00 | 5 | 0 | <0.0001% |
| Dugan Lawrence | director | 116389 0.132% | $86,686.53 | 3 | 0 | <0.0001% |
| Norstrud Andrew James | Chief Financial Officer | 59138 0.0671% | $44,045.98 | 1 | 0 |
$1,606,929 | 98 | 19.13% | $35.4M | |
$69,542,506 | 97 | -20.60% | $51.47M | |
$897,152,484 | 62 | -9.31% | $922.27M | |
$5,395,576 | 49 | 21.35% | $40.06M | |
$663,357 | 37 | 12.91% | $60.51M |
| Increased Positions | 47 | +54.65% | 11M | +73.15% |
| Decreased Positions | 40 | -46.51% | 9M | -57.88% |
| New Positions | 25 | New | 6M | New |
| Sold Out Positions | 28 | Sold Out | 8M | Sold Out |
| Total Postitions | 93 | +8.14% | 18M | +15.27% |
| Polar Asset Management Partners Inc. | $9,550.00 | 7.94% | 5M | +5M | New | 2025-09-30 |
| Alyeska Investment Group, L.P. | $2,388.00 | 1.98% | 1.25M | +1M | New | 2025-09-30 |
| Mmcap International Inc. Spc | $1,465.00 | 1.22% | 766,933 | +766,933 | New | 2025-09-30 |
| Ubs Group Ag | $1,446.00 | 1.2% | 757,244 | +720,990 | +1,988.72% | 2025-09-30 |
| Susquehanna International Group, Llp | $1,435.00 | 1.19% | 751,479 | +637,356 | +558.48% | 2025-09-30 |
| Vanguard Group Inc | $1,358.00 | 1.13% | 710,744 | +209,907 | +41.91% | 2025-09-30 |
| Blackrock, Inc. | $1,303.00 | 1.08% | 682,037 | +682,037 | New | 2025-09-30 |
| Marex Group Plc | $1,230.00 | 1.02% | 644,176 | +644,176 | New | 2025-09-30 |
| Shariaportfolio, Inc. | $1,189.00 | 0.99% | 622,728 | +622,728 | New | 2025-09-30 |
| Jane Street Group, Llc | $1,174.00 | 0.98% | 614,870 | +614,870 | New | 2025-09-30 |